Pol F. Boudes
2021 - Galectin Therapeutics
In 2021, Pol F. Boudes earned a total compensation of $923.7K as Chief Medical Officer at Galectin Therapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Bonus | $136,500 |
|---|---|
| Option Awards | $235,126 |
| Salary | $452,583 |
| Other | $99,474 |
| Total | $923,683 |
Boudes received $452.6K in salary, accounting for 49% of the total pay in 2021.
Boudes also received $136.5K in bonus, $235.1K in option awards and $99.5K in other compensation.
Rankings
In 2021, Pol F. Boudes' compensation ranked 9,038th out of 12,415 executives tracked by ExecPay. In other words, Boudes earned more than 27.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,038 out of 12,415 | 27th |
Division Manufacturing | 4,015 out of 5,505 | 27th |
Major group Chemicals And Allied Products | 1,764 out of 2,375 | 26th |
Industry group Drugs | 1,569 out of 2,096 | 25th |
Industry Pharmaceutical Preparations | 1,169 out of 1,546 | 24th |
Source: SEC filing on October 17, 2022.
Boudes' colleagues
We found two more compensation records of executives who worked with Pol F. Boudes at Galectin Therapeutics in 2021.